Inventor
DAVID URECH
Inventor
CH
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides33%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
H01HElectric switches10%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12NMicroorganisms or enzymes3%
PatentTitleYear
12,503,505Multispecific antibodies having specificity for TNFa and IL-17A, antibodies targeting IL-17A, and methods of use thereof202512,387,883System and method of detecting a welded contact202512,202,911Multispecific antibody comprising CD137 binding domain and PDL1 binding domain202512,098,203Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA202411,879,005Hetero-dimeric multi-specific antibody format202411,862,412System and method for reduced torque switching202411,858,981Humanization of rabbit antibodies using a universal antibody framework202411,578,123Stable and soluble antibodies inhibiting TNFa202311,437,202Switching device with lock open component202211,427,628Antibody frameworks202211,421,035Stable antibody variable domain framework combinations and methods of use thereof202211,319,371Anti-CD3 antibodies202211,236,150Hetero-dimeric multi-specific antibody format2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to Numab Therapeutics AG (8)· patent assignee history
2022–2025Patents assigned to ROCKWELL AUTOMATION SWITZERLAND GMBH (3)· patent assignee history
2022–2025Based in CH· patent location history
2023–2024Patents assigned to NOVARTIS AG (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Numab Therapeutics AG | 8 | 2022–2025 |
| ROCKWELL AUTOMATION SWITZERLAND GMBH | 3 | 2022–2025 |
| NOVARTIS AG | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 13 | 2022–2025 |